547 Stock Overview
A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 13.80 |
| 52 Week High | DKK 20.60 |
| 52 Week Low | DKK 12.70 |
| Beta | 0.81 |
| 1 Month Change | -12.66% |
| 3 Month Change | -24.18% |
| 1 Year Change | 7.81% |
| 3 Year Change | -34.91% |
| 5 Year Change | n/a |
| Change since IPO | -43.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| 547 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -5.5% | -2.3% | -1.4% |
| 1Y | 7.8% | -6.9% | 8.0% |
Return vs Industry: 547 exceeded the German Medical Equipment industry which returned -7.2% over the past year.
Return vs Market: 547 matched the German Market which returned 8.1% over the past year.
Price Volatility
| 547 volatility | |
|---|---|
| 547 Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.9% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 547 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 547's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 5,196 | Britt Jensen | www.ambu.com |
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| 547 fundamental statistics | |
|---|---|
| Market cap | €3.83b |
| Earnings (TTM) | €31.50m |
| Revenue (TTM) | €722.62m |
121.5x
P/E Ratio5.3x
P/S RatioIs 547 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 547 income statement (TTM) | |
|---|---|
| Revenue | DKK 5.39b |
| Cost of Revenue | DKK 2.19b |
| Gross Profit | DKK 3.20b |
| Other Expenses | DKK 2.97b |
| Earnings | DKK 235.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 59.38% |
| Net Profit Margin | 4.36% |
| Debt/Equity Ratio | 0% |
How did 547 perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield43%
Payout RatioDoes 547 pay a reliable dividends?
See 547 dividend history and benchmarks| Ambu dividend dates | |
|---|---|
| Ex Dividend Date | Dec 06 2024 |
| Dividend Pay Date | Dec 23 2024 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 4 days |
Does 547 pay a reliable dividends?
See 547 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 11:13 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ambu A/S is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Healy | Berenberg |
| Alexander Berglund | BofA Global Research |
| Lars Topholm | Carnegie Investment Bank AB |